Basarir H, Kruger J, Brennan A, Thokala P, Jacques R, Dixon S, Elliott J, Heller S, Mansell P. The cost-effectiveness of structured education delivery over 5 weeks versus 5 days for type-1 diabetes mellitus using the Sheffield type-1 diabetes policy model. Poster presented at the 2013 Health Technology Assessment international (HTAi) Conference; 2013. Seoul, South Korea.
Colosia AD, Palencia R, Khan S. Prevalence of hypertension and/or obesity in patients with type 2 diabetes mellitus throughout the world: a systematic literature review. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 9, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A496.
Colosia AD, Palencia R, Khan S. Prevalence of hypertension and/or obesity in patients with type 2 diabetes mellitus in Asia: a systematic literature review. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A661.
Mersey J, Wei W, Meyers J, Wang CC, Dalal MR, Bromberger LA, Levin P. Real-world treatment patterns and outcomes when initiating once-daily injectable pen therapy with insulin glargine or liraglutide - an electronic medical records study. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A494. doi: 10.1016/j.jval.2012.08.1648
Pearson IV, Wolowacz SE, Irving AH, Brockbank JA, Chubb B, Gundgaard J, Briggs A, Davies M. A systematic review of recent data describing the risk of complications in type 1 diabetes mellitus patients. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 9, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A496-7.
Badia X, Forsythe A, Nelson LM, Coles TM, McLeod LD, Webb SM. Improvements in health-related quality of life in acromegaly with pasireotide LAR and octreotide LAR: results from a large, randomized, double-blind phase III trial. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A505.
Davis KL, Tangiral K, Meyers JL, Wei W. Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy. Poster presented at the 48th Annual Meeting of the European Association for the Study of Diabetes; October 2012.
Dalal M, Ling Z, Davis KL, Meyers JL, Digenio A. Real-world characteristics of patients with type 2 diabetes on basal insulin initiating add-on GLP-1 analog therapy. Poster presented at the 48th Annual Meeting of the European Association for the Study of Diabetes; October 2012.
Digenio A, Ling Z, Davis KL, Meyers JL, Dalal M. Real-world characteristics of patients with type 2 diabetes initiating insulin glargine plus liraglutide or insulin glargine plus exenatide. Poster presented at the 48th Annual Meeting of the European Association for the Study of Diabetes; October 2012.
Badia X, Roset M, Forsythe A, Coles TM, McLeod LD, Nelson LM. Clinical and patient-reported outcomes associated to pasireotide in patients with Cushing's disease. Poster presented at the 15th Annual Congress of the European Neuroendocrine Association; September 2012.
Martín-Merino E, Fortuny J, Rivero E, García-Rodríguez LA. Risk factors for incident diabetic retinopathy in type II diabetes in UK primary care. Presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; June 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):S3.
Martín-Merino E, Fortuny J, Rivero E, García-Rodríguez LA. Validation of diabetic retinopathy and maculopathy diagnoses recorded in a United Kingdom primary care database. Presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):S164-5.
Martín-Merino E, Fortuny J, Rivero E, García-Rodríguez LA. Incidence of diabetic maculopathy among patients with diabetic retinopathy. Poster presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):S272.
Martín-Merino E, Fortuny J, Rivero E, García-Rodríguez LA. Risk factors for incident diabetic macular edema in type II diabetes in UK primary care. Poster presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):S272-3.
Wolowacz SE, Pearson IV, Roskell NS, Shannon PR, Chubb B, Gundgaard J. Development and validation of a cost-utility model for Type 1 diabetes mellitus. Presented at the Mount Hood Six Challenge; June 7, 2012.
Saffar D, Williams K, Lafata JE, Divine G, Pladevall M. Racial disparities in lipid control in patients with diabetes. Am J Manag Care. 2012 Jun 1;18(6):303-11.
Davis KL, Wei W, Meyers JL, Kilpatrick B, Pandya N. Are clinical outcomes associated with different A1C levels in elderly patients? Poster presented at the 72nd Scientific Sessions of the American Diabetes Association; June 2012.
Davis KL, Wei W, Kilpatrick BS, Meyers JL, Pandya N. Use of basal insulins in elderly nursing home residents with type 2 diabetes mellitus: a retrospective chart review study. Poster presented at the Annual Scientific Meeting of the American Geriatric Society; May 2012.
Davis KL, Wei W, Meyers J, Kilpatrick BS, Pandya N. A retrospective study of basal insulin analogs in elderly nursing home residents with type-2 diabetes. Poster presented at the 2012 American Geriatrics Society Annual Scientific Meeting; April 2012. [abstract] J Am Geriatr Soc. 2012 Apr; 60(S4):S51.
Pandya N, Wei W, Kilpatrick BS, Meyers JL, Davis KL. Too many finger sticks for nothing? A study of sliding scale insulin use among elderly nursing home residents with type 2 diabetes. Poster presented at the 2012 American Geriatrics Society Annual Scientific Meeting; April 2012. [abstract] J Am Geriatr Soc. 2012 Apr; 60(S4):S126.
Martín-Merino E, Fortuny J, Rivero E, García-Rodríguez LA. Validation of diabetic retinopathy and maculopathy diagnoses recorded in a UK primary care database. Diabetes Care. 2012 Apr;35(4):762-7.
Meyers JL, Parasuraman S, Bell K, Graham JB, Candrilli SD. The high-cost type 2 diabetes mellitus patient: findings from a United States managed care population. Poster presented at the 24th Annual American Managed Care Pharmacy Meeting & Expo; April 2012.
Pandya N, Wei W, Kilpatrick B, Meyers JL, Davis KL. Too many finger sticks for nothing? A study of sliding scale insulin use among elderly nursing home residents with type 2 diabetes. Poster presented at the Annual Meeting and Convention of the American Society of Consultant Pharmacists; November 2011.
McLeod LD, Pulgar S, Nelson LM, Maldonado M, Gilligan T, Zhang Y. Psychometric evaluation of the Cushing's quality of life questionnaire (CushingQOL). Poster presented at the 18th Annual Conference of the International Society for Quality of Life Research; October 2011.
Hirsch IB, Xu Y, Davis KL, Calingaert B. Patient factors associated with glucagonlike peptide 1 receptor agonist use with and without insulin. Endocr Pract. 2011 Sep 1;17(5):707-16.
McKenna SP, Wilburn J, Twiss J, Crawford SR, Hána V, Karbownik-Lewinska M, Popovic V, Pura M, Koltowska-Häggström M. Adaptation of the QoL-AGHDA scale for adults with growth hormone deficiency in four Slavic languages. Health Qual Life Outcomes. 2011 Aug 2;9:60. doi: 10.1186/1477-7525-9-60
Pandya N, Wei W, Kilpatrick BS, Meyers JL, Davis KL. Burden of sliding scale insulin use in elderly long-term care residents with type 2 diabetes. Poster presented at the National Conference of the National Association of Directors of Nursing Administration in Long Term Care; July 2011.
Johnson ML, Parikh R, Rajan SS, Aparasu R. Effect of ACEI and ARB on health related quality of life in patients with hypertension and diabetes. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 2011. Baltimore, MD. [abstract] Value Health. 2011 May; 14(3):A46.
Meyers JL, Candrilli SD, Kovacs B. Type 2 diabetes mellitus and renal impairment in a large outpatient electronic medical records database: rates of diagnosis and antihyperglycemic medication dose adjustment. Postgrad Med. 2011 May 1;123(3):133-43.
Parikh RC, Shah AJ, Rajan SS, Aparasu R, Johnson ML. Quality of care among adult patients with diabetes and hypertension. Poster presented at the 23rd Academy of Managed Care Pharmacy Conference; April 2011. Minneapolis, MN.
Lang K, Meyers JL, Kovacs B, Candrilli SD. Renal impairment in patients with type 2 diabetes mellitus and associated antihyperglycemic medication adjustment: evidence from an electronic medical records database. Poster presented at the 43rd Annual Meeting and Scientific Exposition of the American Society of Nephrology; November 2010.
Lee LJ, Fahrbach JL, Nelson LM, McLeod LD, Martin SA, Sun P, Weinstock RS. Effects of insulin initiation on patient-reported outcomes in patients with type 2 diabetes: results from the DURABLE trial. Diabetes Res Clin Pract. 2010 Aug 1;89(2):157-66.
Horton ES, Silberman C, Davis KL, Berria R. Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort database. Diabetes Care. 2010 Aug 1;33(8):1759-65.
Martín-Merino M, Fortuny J, Plana E, Rivero E, García-Rodríguez LA. Incidence of diabetic retinopathy and diabetic macular edema in newly diagnosed type I and type 2 diabetic patients. Poster presented at the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(Suppl 1):S251-2.
Habib ZA, Havstad SL, Wells K, Divine G, Pladevall-Vila M, Wiliams LK. Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010 Feb;95(2):592-600.
Nichols GA, Gandra SR, Chiou CF, Anthony MS, Alexander-Bridges M, Brown JB. Successes and challenges of insulin therapy for type 2 diabetes in a managed-care setting. Curr Med Res Opin. 2010 Jan;26(1):9-15. doi: 10.1185/03007990903417679
Hoerger TJ, Zhang P, Segel JE, Gregg EW, Venkat Narayan KM, Hicks KA. Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancy. Diabetes Res Clin Pract. 2009 Dec 1;86(3):225-32.
Chatzi L, Plana E, Pappas A, Alegkakis D, Karakosta P, Daraki V. The metabolic syndrome in early pregnancy and risk of gestational diabetes mellitus. Diabetes Metab. 2009 Dec;35(6):490-4.
Curtis B, Hayes C, Fehnel SE, Kolotkin R. Assessing the impact of weight loss among obese individuals with type 2 diabetes mellitus. Poster presented at the 27th Annual Scientific Meeting of the Obesity Society; October 1, 2009.
Berria R, Rosenstock J, Silberman C, Davis KL, Horton ES. Weight loss and associated changes in glycaemic control and cardiovascular biomarkers in patients with type 2 diabetes mellitus receiving incretin therapies in a large cohort database. Poster presented at the 44th General Assembly of the European Association for the Study of Diabetes; September 2009. [abstract] Diabetologia. 2009 Sep; 52(Suppl. 1, Abst.755):S297.
Hoerger TJ, Zhang P, Segel JE, Gregg EW, Narayan K, Hicks KA. Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancy. Presented at the 7th World Conference on Health Economics; July 2009. Previously presented at the American Diabetes Association 69th Scientific Sessions.
Hoerger TJ, Zhang P, Segel JE, Gregg E, Narayan K, Hicks KA. Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancy. Presented at the American Diabetes Association 69th Scientific Sessions; June 2009.
Lee J, McLeod LD, Nelson LM, Hill C, Sweeney CT, Sun P. Initiation of insulin therapy improves self-reported diabetes symptoms in patients (Pts) with type 2 diabetes (T2D) on oral agents. Poster presented at the 69th Scientific Sessions of the American Diabetes Association; June 2009.
Habib ZA, Tzogias L, Havstad SL, Wells K, Divine G, Lanfear DE, Tang J, Krajenta R, Pladevall-Vila M, Williams LK. Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis. Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):437-47. doi: 10.1002/pds.1722
Lee LJ, Nelson LM, McLeod LD, Hill CD, Sweeney CT. Effects of insulin therapy on the Diabetes Symptom Checklist-Revised (DSC-R): data from a large insulin clinical trial. Poster presented at the 2009 ISPOR 14th Annual International Meeting; May 21, 2009. [abstract] Value Health. 12(3):A105.
Khan SB, Zagar AJ, Hayes CP, DiBenedetti DB, Zhou X, Price M, Van Brunt DL. Assessment of type 2 Diabetes mellitus patients with and without symptoms of ADHD: patient characteristics and resource utilization data from an internet-based survey. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 14th Annual International Meeting; May 15, 2009. Orlando, FL. [abstract] Value Health. 2009 May 1; 12(3):A181-2.
Williams GC, Patrick H, Niemiec CP, Williams LK, Divine G, Lafata JE, Heisler M, Tunceli K, Pladevall-Vila M. Reducing the health risks of diabetes: how self-determination theory may help improve medication adherence and quality of life. Diabetes Educ. 2009 Mar 26;35(3):484-92.
Alvarez-Pedrerol M, Guxens M, Mendez M, Canet Y, Martorell R, Espada M, Plana E. Iodine levels and thyroid hormones in healthy pregnant women and birth weight of their offspring. Eur J Endocrinol. 2009 Mar;160(3):423-9.
Anderson RT, Girman CJ, Pawaskar MD, Camacho FT, Calles J, Kelly WS, DeMuro C, Balkrishnan R. Diabetes medication satisfaction tool: a focus on treatment regimens. Diabetes Care. 2009 Jan 1;32(1):51-3.
Patel PA, Zyczynski TM, Beard SM, Earnshaw SR, McDade CL, Zimovetz E. A European multicountry comparison of the cost-effectiveness of iodixanol versus iohexol based on the results of the NEPHRIC clinical trial. Poster presented at the 2008 ISPOR 11th Annual European Congress; November 2008. Athens, Greece.